Importance of the intestinal microbiota in ocular inflammatory diseases: A review
Author:
- 4 March 2019
- journal article
- review article
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 47 (3) , 418-422
Abstract
The purpose of this article is to review the literature on relationships between the intestinal microbiota and ocular inflammatory disease, specifically non‐infectious uveitis and age‐related macular degeneration. The importance of the intestinal microbiota in uveitis pathogenesis has been shown by multiple groups demonstrating that alterations in the microbiota induced by certain oral antibiotics results in reduced uveitis severity, and another group demonstrating that a commensal intestinal bacterial antigen activates retina‐specific autoreactive T cells, potentially indicating a commensal trigger for uveitis. Additionally, commensal intestinal bacterial metabolite short chain fatty acids can be utilized to suppress autoimmune uveitis. Age‐related macular degeneration is associated with intestinal dysbiosis, which is partially influenced by genetic risk alleles and AREDS supplementation. Strategies for therapeutically targeting the intestinal microbiota might involve several approaches, including the use of antibiotics, dietary changes, drugs that supplement beneficial bacterial metabolites or target causative bacterial strains, dietary strategies or faecal microbial transplantation. In summary, the intestinal microbiota are at the cross‐roads of genetic and environmental factors that can promote ocular conditions such as non‐infectious uveitis and age‐related macular degeneration, partially via its dynamic influence on mucosal and systemic immunity. The intestinal microbiome thus represents a salient potential target for therapeutic modulation to treat these potentially blinding conditions.Keywords
Funding Information
- National Institutes of Health (P30 EY010572)
- Alcon Research Institute (Young Investigator Award)
- Collins Medical Trust (Award)
- Edward N. and Della L. Thome Memorial Foundation (Program in Age‐Related Macular Degeneration Researh)
- National Eye Institute (K08 EY022948, P30 EY010572)
- Oregon Health and Science University (Physician‐Scientist Award)
- Research to Prevent Blindness (Career Development Award, Unrestricted departmental funding)
This publication has 31 references indexed in Scilit:
- HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic RatsPLOS ONE, 2014
- Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritiseLife, 2013
- The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell HomeostasisScience, 2013
- Systematic Review of Intestinal Microbiota Transplantation (Fecal Bacteriotherapy) for Recurrent Clostridium difficile InfectionClinical Infectious Diseases, 2011
- Induction of Colonic Regulatory T Cells by Indigenous Clostridium SpeciesScience, 2011
- Central Nervous System Demyelinating Disease Protection by the Human Commensal Bacteroides fragilis Depends on Polysaccharide A ExpressionThe Journal of Immunology, 2010
- Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProceedings of the National Academy of Sciences of the United States of America, 2010
- Genetic control of the alternative pathway of complement in humans and age-related macular degenerationHuman Molecular Genetics, 2009
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- Systemic Complement Activation in Age-Related Macular DegenerationPLOS ONE, 2008